QIAGEN Unveils Diagnostic Assay in the EU to Detect Genetic Variation Causing Adverse Reactions in AIDS Patients
QIAGEN (Nasdaq: QGEN; Frankfurt Prime Standard: QIA) today announced that it has introduced a new molecular diagnostic t…
QIAGEN (Nasdaq: QGEN; Frankfurt Prime Standard: QIA) today announced that it has introduced a new molecular diagnostic t…
In einem gemeinsamen Schreiben an den Südwestrundfunk (SWR) unterstützen der Landesbischof der evangelischen Landeskirch…
/pressemitteilung/pdf/22288/meldung.pdf